Sucampo Reports Third Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Sucampo Pharma (SCMP) Tops Q3 EPS by 2c; Raises Outlook
November 1, 2017 6:33 AM EDTSucampo Pharma (NASDAQ: SCMP) reported Q3 EPS of $0.27, $0.02 better than the analyst estimate of $0.25. Revenue for the quarter came in at $61.3 million versus the consensus estimate of $58.05 million.
GUIDANCE:
Sucampo Pharma sees FY2017 EPS of $1.10-$1.15, versus the consensus of... More
